Neurodegenerative Disease in the UK: Takeda, NIHR & UCL Research Collaboration
Takeda Cambridge (the UK subsidiary of global biotech Takeda Pharmaceuticals) will now collaborate with University…
October 15, 2015 - 2 minutes
Neurological disorders
Spanish connection: VC leads Biotech series A Fund to cure Rare Neurodegenerative Disease
Minoryx Therapeutics is a Barcelona based Rare-disease specialist who has a panel of orphan-drug experts…
October 15, 2015 - 2 minutes
High-Risk Infant Cancer: Nature publishes on a New and Reliable Biomarker from Cologne
New Oncology from Cologne (Germany) is a biotech which today published a paper in Nature on…
October 14, 2015 - 4 minutes
TauRX, the leading Alzheimer-focused Biotech, earns funding after Phase II breakthrough
The Tau protein has already been implicated in the onset of Alzheimer's, with many biotechs…
October 9, 2015 - 3 minutes
Asceneuron’s latest stab at the Alzheimer’s challenge with Sofinnova
Paris based Sofinnova continues to invest in the Alzheimer's fight, with a €27.5M pot given…
October 1, 2015 - 2 minutes
New Smart Collaboration of Nestlé and AC Immune Against Alzheimer’s disease
Nestlé Institute of Health Sciences (NIHS) is teaming up with the Swiss AC Immune to…
September 28, 2015 - 2 minutes
UniQure’s cure for rare Lysosomal disease ready for phase III trial
UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial…
September 22, 2015 - 3 minutes
AC Immune receives Milestone Payment for Alzheimer Antibody
AC Immune received a first milestone payment from Roche’s subsidiary Genentech. The latter picked up…
July 17, 2015 - 2 minutes
After being rejected twice, Horizon pushes Depomed to accept its €2.7Bn offer
Horizon Pharma is getting anxious and has offered the substantial amount of €2.7Bn to buy its…
July 13, 2015 - 1 minute
First-in-human successful Phase I for an Alzheimer’s vaccine
AXON Neuroscience has completed a pioneer Phase I that offers new hope for millions of…
July 10, 2015 - 2 minutes
Roche and Evotec knocked down by their Alzheimer candidate
The progressive aging of the population in developed countries is turning Alzheimer into one of…
July 2, 2015 - 2 minutes
Alkermes presents its new treatment of Alzheimer’s agitation
Alkermes reveals a new drug candidate, ALKS 7119, for treatment of Alzheimer’s agitation, depression and…
March 4, 2015 - 2 minutes
